MolNFT v1 · #103965 · protein

Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acid

4PWI: “Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acid”. X-ray diffraction, 1 ligand (ROA), 1 pocket (best druggability 0.36). MolNFT v1 #103965 on GenesisL1: 3D structure, binding sites and pockets in…

PDB: 4PWI
Type: protein
Length: 226 residues
Chains: 2
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Transthyretin
UniProt: P02766
Ligands: ROA
Pockets: 1 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 53% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Transthyretin	protein	115	6% helix, 53% strand	P02766
B	Transthyretin	protein	111	6% helix, 53% strand	P02766

Ligands and binding sites

ROA · (2R)-3-(3,4-dihydroxyphenyl)-2-{[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}propanoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	82	0.36	0.76	16	empty

Interfaces

1 interface between chains.

A–B · 912 Å² buried · 21 hydrogen bonds · protein-protein

Compared structures

4PWI · Crystal structure of V30M mutant human transthyretin complexed with rosmarinic acid · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P02766
Elsewhere: RCSB PDB 4PWI · PDBe 4PWI · UniProt P02766

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.